Home
The organising committee warmly invite you to join us in The Theranostics Center. The theme for 2025 is If you can see it, you can treat it and the purpose of this conference is to educate, promote and support the application and use of radio-labelled agents in the diagnosis and treatment of cancer. Building on principles first established using radio-iodine for imaging and treatment of thyroid cancer, theranostics is entering an exciting phase of its evolution with new targets being identified and increasing evidence of the success and wider applicability of this approach. Viagra 100mg - πόσο μπορούμε να πάρουμε από αυτό και τις αρνητικές επιπτώσεις του
The conference will feature presentations on molecular imaging tracers that allow selection and prediction of response to radionuclide therapies as well as the latest information on radionuclide therapy trials. This fascinating program will be supported by a respected and international panel of expert practitioners. (To learn more about the Australian and international speakers who have accepted invitations to share their expertise at the Congress please click here.)
The disease focus will be neuroendocrine tumours and prostate cancer with exciting and innovative theranostic advances being presented from around the globe. Updates on somatostatin receptor imaging and Peptide Receptor Radionuclide Therapy (PRRT) of neuroendocrine tumours and PSMA imaging and therapy of prostate cancer will be of particular interest to clinicians working with these diseases. Priligy 30mg e voi. I pro, i contro e tutto il resto
All abstracts will be reviewed by the committee. Please note that only a limited number of abstracts will be selected for oral presentations and therefore some presenters may be assigned a poster presentation even if they have specified for an oral presentation.
Abstract Categories
Abstract categories available for submission include:
* Neuroendocrine tumours
* Prostate cancer
* Other theranostics
Within these categories you can also choose a sub-category focus:
* Clinical
* Radiochemistry
* Dosimetry
* Other
Dr. Saul Hertz: RAI The Origin of Theranostics
An exciting feature of the 2016 Theranostics World Congress is the The Saul Hertz (1905-1950) and the Origin of Nuclear Medicine exhibit. This exhibition will be displayed alongside the poster panels during the conference. Ein zusammenfassender Überblick über Cialis als Behandlungsform für erektile Dysfunktion
The Saul Hertz (1905-1950) and the Origin of Nuclear Medicine exhibit celebrates Dr. Hertz as the founding father of theranostics. Highlighted are vivid images, vintage newspaper articles, journal reprints and the Data Charts from the world's first patients treated successfully with a nuclear substance-radioiodine (RAI). Dr Hertz overcame the challenges of the intolerance of being an outsider, institutional politics, stolen intellectual property as well as his work being interrupted by World War II to bring his paradigm changing work to fruition. He envisioned the tracer method of holding the key to Cancer in general. Saul Hertz's success of developing the medical uses radioiodine (RAI) is the first and Gold Standard of targeted Cancer therapy.
Our Sponsors







